Disclosures for "Bing-Neel Syndrome: An Atypical Complication of Waldenström Macroglobulinemia – A Case Report"
-
Dr. Belbraouet has nothing to disclose.
-
Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
-
Dr. Chedrawe has nothing to disclose.
-
Dr. Murphy has nothing to disclose.